Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-27 Purchase |
2023-03-29 7:30 pm |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director |
207,840 | $4.0467 | $841,063 | 2,868,994 (Indirect) |
View |
| 2022-12-15 Purchase |
2022-12-19 08:30 am |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
21,500 | $1.39 | $29,885 | 105,441 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-21 6:04 pm |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
1,355,000 | $3.69 | $4,999,950 | 4,174,379 (Indirect) |
View |
| 2022-04-19 Purchase |
2022-04-20 6:22 pm |
Inozyme Pharma Inc. | INZY | Pivotal bioVenture Partners Fund I L.P. Pivotal bioVenture Partners Fund I G.P. L.P. Pivotal bioVenture Partners Fund I U.G.P. Ltd Director |
1,070,000 | $3.69 | $3,948,300 | 2,661,154 (Indirect) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:05 pm |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
27,100 | $3.69 | $99,999 | 80,626 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:05 pm |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
67,750 | $3.69 | $249,998 | 258,575 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:05 pm |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director |
1,070,000 | $3.69 | $3,948,300 | 2,661,154 (Indirect) |
View |
| 2022-04-19 Purchase |
2022-04-20 4:05 pm |
Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO |
27,100 | $3.69 | $99,999 | 27,100 (Direct) |
View |
| 2021-06-24 Sale |
2021-06-25 07:58 am |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0.0001 | $7 | 291,305 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-23 Option Award |
2023-03-27 4:05 pm |
N/A 2033-03-22 |
Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-04 08:00 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
3,315 | $2.28 | 261,890 (Direct) |
View |
| 2022-09-30 Option Award |
2022-10-04 08:00 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
3,315 | $2.28 | 83,941 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 4:32 pm |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:52 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:51 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:49 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:48 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Edwards Martin Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:47 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:45 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-03-21 Option Award |
2022-03-22 4:11 pm |
N/A 2032-03-20 |
Inozyme Pharma Inc. | INZY | Subramanian Sanjay SVP, CFO |
180,000 | $0 | 180,000 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 07:47 am |
N/A 2032-02-23 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 07:45 am |
N/A 2032-02-23 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
115,000 | $0 | 115,000 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 07:58 am |
N/A 2027-06-27 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0 | 291,305 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-25 07:58 am |
N/A N/A |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
66,788 | $0.98 | 291,305 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 07:48 am |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Bhagat Sarah M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 5:32 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Mathers Edward T Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:17 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Edwards Martin Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:16 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:14 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Sullivan Lynne Marie Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:12 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:11 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | DIAZ REINALDO M Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:10 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Inozyme Pharma Inc. Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-05-17 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-16 |
Inozyme Pharma Inc. | INZY | DiPalma Stephen J. Interim CFO |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-24 Option Award |
2021-03-25 4:05 pm |
N/A 2031-03-23 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:57 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Jungles Steven J SVP, CTO |
42,000 | $0 | 42,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Bolte Axel Chief Executive Officer |
117,000 | $0 | 117,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Bjarke Henric Bjorn SVP, COO |
51,000 | $0 | 51,000 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-17 5:56 pm |
N/A 2031-03-03 |
Inozyme Pharma Inc. | INZY | Basso Stephen SVP Finance (PFO) |
27,000 | $0 | 27,000 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-04 5:11 pm |
N/A 2031-02-01 |
Inozyme Pharma Inc. | INZY | Wenkert Deborah SVP, CMO |
100,000 | $0 | 100,000 (Direct) |
View |